Idaho, Kansas and Missouri can pursue legal action to prohibit the Food and Drug Administration from allowing online prescriptions.

A Texas federal judge Thursday ruled Idaho, Kansas, and Missouri can join a case challenging access to the abortion pill. Trump-appointed Judge Matthew Kacsmaryk allowed the states to pursue legal action in Texas that seeks to prohibit the Food and Drug Administration (FDA) from allowing online prescriptions for Mifepristone over concerns that it could “undermine state abortion laws and frustrate state law enforcement,

The Republican-led states of Idaho, Missouri and Kansas can proceed with a lawsuit seeking to restrict the availability of the abortion pill mifepristone in the United States, a federal judge in Texas ruled on Thursday.

A federal judge in Texas ruled that three states can challenge the current rules of accessibility for abortion pills.

The Food and Drug Administration announced a new proposal Tuesday that would require food and drink manufacturers to place nutrition labels on the front of their products instead of the back.

The FDA announced on Wednesday that it has banned the use of Red No. 3, an additive used to give food and drinks a cherry-red color.

A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill mifepristone nationwide.

The order is a reminder that Americans live in two different worlds regarding the government’s use of the ultimate punishment.

After the Supreme Court overturned Roe in 2022, anti-abortion advocates launched a barrage of litigation, including a federal suit in Texas aimed at mifepristone, one drug in a two-drug regimen used in medication abortions.

Here are some of the actions Trump’s nominees could take on abortion, if confirmed, from HHS to the Justice Department.

Efforts to limit access to the abortion drug mifepristone have gotten boost from a federal judge who took the bench

In an effort to better track the health impacts of hemp-derived cannabinoid products in the U.S., the Food and Drug Administration (FDA) is proposing that CBD and other hemp-derived cannabinoids be added as selectable options on federal documents used by healthcare professionals,